Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The microbiome and human cancer
Gregory D. Sepich‐Poore, Laurence Zitvogel, Ravid Straussman, et al.
Science (2021) Vol. 371, Iss. 6536
Open Access | Times Cited: 816

Showing 1-25 of 816 citing articles:

The role of ROS in tumour development and progression
Eric C. Cheung, Karen H. Vousden
Nature reviews. Cancer (2022) Vol. 22, Iss. 5, pp. 280-297
Closed Access | Times Cited: 909
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Jorge Luis Galeano Niño, Hanrui Wu, Kaitlyn D. LaCourse, et al.
Nature (2022) Vol. 611, Iss. 7937, pp. 810-817
Open Access | Times Cited: 403
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
Khiem C. Lam, Romina E. Araya, April Huang, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5338-5356.e21
Open Access | Times Cited: 347
Microbiome and cancer
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 336
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 295
Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
Lian Narunsky-Haziza, Gregory D. Sepich‐Poore, Ilana Livyatan, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3789-3806.e17
Open Access | Times Cited: 286
Meta-hallmarks of aging and cancer
Carlos López‐Otín, Federico Pietrocola, David Roiz‐Valle, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 12-35
Open Access | Times Cited: 233
A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors
Anders B. Dohlman, Jared Klug, Marissa Mesko, et al.
Cell (2022) Vol. 185, Iss. 20, pp. 3807-3822.e12
Open Access | Times Cited: 204
Engineered cellular immunotherapies in cancer and beyond
Amanda Finck, Tatiana Blanchard, Christopher P. Roselle, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 678-689
Open Access | Times Cited: 191
Engineering bacteria as interactive cancer therapies
Candice R. Gurbatri, Nicholas Arpaia, Tal Danino
Science (2022) Vol. 378, Iss. 6622, pp. 858-864
Open Access | Times Cited: 182
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy, John Lenehan, Wilson H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2121-2132
Closed Access | Times Cited: 173
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy
Yang Li, Aitian Li, Ying Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 165
Chemically and Biologically Engineered Bacteria‐Based Delivery Systems for Emerging Diagnosis and Advanced Therapy
Zhaoting Li, Yixin Wang, Jun Liu, et al.
Advanced Materials (2021) Vol. 33, Iss. 38
Closed Access | Times Cited: 158
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 155
The coming decade in precision oncology: six riddles
Adam Wahida, Lars Buschhorn, Stefan Fröhling, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 1, pp. 43-54
Closed Access | Times Cited: 125
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Lisa Derosa, Bertrand Routy, Antoine Desîlets, et al.
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2396-2412
Open Access | Times Cited: 111
Embracing cancer complexity: Hallmarks of systemic disease
Charles Swanton, Elsa Bernard, Chris Abbosh, et al.
Cell (2024) Vol. 187, Iss. 7, pp. 1589-1616
Open Access | Times Cited: 103
Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
Weibo Zhong, Kaihui Wu, Zining Long, et al.
Microbiome (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 96
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Connor Campbell, Mrunmayee Kandalgaonkar, Rachel M. Golonka, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 294-294
Open Access | Times Cited: 96
Fusobacterium nucleatum and cancer
Tamar Alon‐Maimon, Ofer Mandelboim, Gilad Bachrach
Periodontology 2000 (2022) Vol. 89, Iss. 1, pp. 166-180
Open Access | Times Cited: 93
Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes
Baylee J. Russell, Steven D. Brown, Nicole Siguenza, et al.
Cell (2022) Vol. 185, Iss. 17, pp. 3263-3277.e15
Open Access | Times Cited: 88
Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Ruize Qu, Yi Zhang, Yanpeng Ma, et al.
Advanced Science (2023) Vol. 10, Iss. 23
Open Access | Times Cited: 83
Probiotic-guided CAR-T cells for solid tumor targeting
Rosa L. Vincent, Candice R. Gurbatri, Fangda Li, et al.
Science (2023) Vol. 382, Iss. 6667, pp. 211-218
Open Access | Times Cited: 83
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 81
Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 81
Page 1 - Next Page

Scroll to top